Institute for Safe Medication Practices

Analysis

Institute for Safe Medication Practices is a registered charity in United States, based in Doylestown, PA. It received its IRS tax-exemption ruling in September 1994, 32 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Institute for Safe Medication Practices reported income of $2.4m and spending of $4.0m, spending 168% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $3.0m to $2.4m (-20%), an average of -5.5% a year. The sharpest change came in the year to December 2021, when income rose by 30%. Over the whole period it spent 130% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Institute for Safe Medication Practices sits at the 73rd percentile: it is larger than about 73% of them. Against every charity in United States with reported income it ranks in the 87th percentile, and in the 86th percentile within PA. Charities of a similar size with the same main cause include Health Research & Educational Trust of New Jersey ($2.4m), Mental Health Advocacy Services Inc ($2.4m) and Kmha Real Estate Inc ($2.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 20% and program service revenue 82% of the total. Compensation of current officers, directors and key employees was $943k (24% of expenses). Other salaries and wages came to $1.1m. At year end it held assets of $2.0m against liabilities of $2.0m, net assets of $26k. It reported 18 employees.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.